Procurement intelligence

Federal contract award

FY26 UDO INITIATIVE - SARS-COV-2 NUCLEOCAPSID AND SPIKE ALPHALISA ASSAYS

REVVITY HEALTH SCIENCES, INC. · Department of Health and Human Services

Value: $39,500
Start: Dec 9, 2020
End: Jan 9, 2021
Action date: May 27, 2026
PIID: 75N95021P00034
Status: completed
NAICS: 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Place of performance: SHELTON, CT
Award type: PURCHASE ORDER

Description

FY26 UDO INITIATIVE - SARS-COV-2 NUCLEOCAPSID AND SPIKE ALPHALISA ASSAYS

Need modifications, related awards, and vendor peers? Open the full award workspace.